SCHEMBL8521196

SCHEMBL8521196

CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(=O)O)C(C)C)C(N)=O

nearest known ligand 0.57

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CALCRL Q16602 1/20 0.57
▸ SLC6A2 P23975 1/20 0.56
▸ REN P00797 1/20 0.54
▸ NMUR2 Q9GZQ4 2/20 0.53
▸ AGTR1 P30556 1/20 0.53
▸ AGTR2 P50052 1/20 0.53
▸ NTSR2 O95665 3/20 0.53
▸ NTSR1 P30989 3/20 0.53
▸ SORT1 Q99523 1/20 0.53
▸ NMUR1 Q9HB89 1/20 0.52
▸ NPY1R P25929 1/20 0.52
▸ NPY2R P49146 1/20 0.52
▸ NPY4R P50391 1/20 0.52
▸ NPY5R Q15761 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8521204 0.96 SLC6A2 (0.56) CALCRLSLC6A2RENNMUR2NTSR2
SCHEMBL30585292 0.91 SLC6A2 (0.60) SLC6A2NTSR2NTSR1SORT1
SCHEMBL30512639 0.86 CALCRL (0.59) CALCRLSLC6A2RENAGTR1AGTR2
SCHEMBL8441486 0.85 KDM1A (0.54) NMUR2NTSR2NTSR1NMUR1NPY1R
SCHEMBL30810418 0.85 SLC6A2 (0.63) CALCRLSLC6A2RENNMUR2AGTR1
SCHEMBL30540721 0.85 NTSR1 (0.57) SLC6A2NTSR2NTSR1SORT1NPY1R
SCHEMBL29836567 0.84 SLC6A2 (0.60) CALCRLSLC6A2NMUR2AGTR1AGTR2
SCHEMBL29796577 0.84 SLC6A2 (0.60) CALCRLSLC6A2NMUR2AGTR1AGTR2
SCHEMBL7443144 0.84 KDM1A (0.62) NMUR2AGTR1AGTR2NTSR2NTSR1
SCHEMBL30445757 0.84 SLC6A2 (0.62) CALCRLSLC6A2REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5962642-A TREATING PROTEIN/PEPTIDE HAVING AMINO TERMINAL ACETYLATED AMINO ACID WITH ACID TO ACETYLATE HYDROXYL GROUP, TREATING WITH ISOTHIOCYANATE COMPOUND IN PRESENCE OF ACID TO FORM THIOCARBAMYL PROTEIN/PEPTIDE, ANALYSIS BY EDMAN DEGRADATION SEIKO INSTRUMENTS INC. (JP) 1999-10-05 — — US disclosed
Send feedback